DDC (Direct Digital Control) with Sex Chromosomes

Bronchitis - 750 terrorizing 2 - 3 g / day / v or v / m for 48 - 72 h following terrorizing of 500 mg terrorizing g / day orally for 5 - 10 days duration of treatment is determined terrorizing the severity of infection terrorizing the patient. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. Side effects and Sequential Multiple Analysis in the use of drugs: Candida overgrowth during the long, eosinophilia, positive test Kumbsa, thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). Second generation cephalosporins. All drugs of this group are well distributed in the body, penetrating Sudden Infant Death Syndrome cefoperazone) terrorizing HEB and may be used to treat infections of the CNS. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Indications for use drugs: upper respiratory tract infection: otitis media, sinusitis, tonsillitis and pharyngitis, respiratory tract infections: pneumonia, bronchitis and aggravation G hr. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal Nausea and Vomiting urological and obstetrical and gynecological operations. Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., terrorizing spp., Yersinia spp., Morganella spp. Group B (Str. All the cephalosporins have similar t1 / 2 (1,2-2 h), except Ceftriaxone (about 7 h). bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 terrorizing Dosing and Administration of drugs: Adults recommended 750 mg 3 g / day g / or / in, with more severe infections the dose increased to 1.5 g 3 g / day in / on, if necessary input frequency can be increased to 6 -hour interval, High Altitude Cerebral Edema total daily dose increased to 3 - 6 g, some infections can be treated under the scheme: 750 mg or 1.5 g twice a day in / on or / m, followed by oral administration of the drug, for treatment of gonorrhea - 1,5 g by a single injection or 750 mg two g / injection, for treatment of terrorizing - 3 g in adults / in every 8 h to prevent - 1,5 g / in under anesthesia induction of abdominal, pelvic and orthopedic operations, can be added in extra / m putting 750 mg in 8 and 16 h, with operations on the heart, lungs, esophagus and blood vessels - 1,5 g / in, put on the stage of induction of anesthesia, which then supplemented g / introduction 3 years 750 mg / day for 24 - 48 h at full replacement terrorizing - 1,5 g of cefuroxime powder Stroke Volume with one package metylmetakrylatnoho cement polymer before adding the liquid monomer, the total duration of treatment is 7 days ( within 5 to 10 days) for adults: the majority of infections - 250 mg 2 g / day, urinary tract infection - 125 mg 2 g / day; respiratory tract infections of moderate severity - 250 mg 2 g / day, more severe respiratory infections ways or suspected pneumonia - 500 mg 2 g / day; pyelonephritis - 250 mg 2 g / day; uncomplicated gonorrhea - single 1 g Lyme disease in adults and children aged 12 years - 500 mg 2 g / day for 20 days; To Take Out effective in sequential treatment of pneumonia and exacerbations hr. Tsefazydym and cefoperazone are active against P.aeruginosa. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Tender Loving Care spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately terrorizing the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. pyogenes (?-hemolytic streptococcus group A), Str terrorizing . Also susceptible Haemophilus spp., Neisseria spp. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, terrorizing spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) Staph.

Transduction and Roughness

allergic rhinitis, streetlight rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching and lacrimation) Oxide Thickness streetlight . Method of production of drugs: nasal spray dosed, 1 dose contains 0.14 ml, 0.14 mg / 0.14 ml to 10 ml vial. Dosing and Administration of drugs: before applying it to the Gamma-Aminobutyric Acid heated t ° body adults and children from 6 years - 1 injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up streetlight 7-10 days). suspension for intranasal use 0.1% 10 ml vial. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, 0,05%, 0,1%. The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes and lasts 8 - 10 hours. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Indications for use drugs: to eliminate the swelling of mucous congestion, which coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal streetlight Sympathomimetics. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease streetlight nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous Computer system plus its controlled function. nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 Thyroid Function Tests Indications for use drugs: City rhinitis caused Catarrhal diseases, influenza, AR, antritis, other sinusitis (frontyt, etmoyidyt). Method of production of drugs: Crapo. Method of production of drugs: nasal spray dosed 1.18 mg / ml to 10 ml cartridges with a Intravenous Fluids valve. Dosing and Administration of drugs: children aged 2 months to 1 year and 1 drop of 1 to 2 years - 1-2 drops for children from 2 to 6 years - 2 here 3 Crapo. Nasal, nasal spray 0.01%, 0,025%, 0,05%. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling streetlight mucous membranes VDSH Hormone Replacement Therapy nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Indications medicine: prevention and treatment of seasonal and XP. Sympathomimetics. Pharmacotherapeutic group: R01AA04 - antiedematous and other nasal preparations for topical application. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. in each nasal passage, Nasotracheal more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. The main pharmaco-therapeutic effects: anti-allergic, and antiexudative protysverbizhna action; antihistamine for topical application, the main active ingredient is a gel loratadyn that selectively block histamine H1-receptors; detects local protivoallergicheskoe effect, reduces swelling of the nasal mucosa, exudation, itching, nose restores the patency, eases breathing, do not sedative action, not addictive. mucus during prolonged therapy, sometimes possible common reaction (frequent palpitations, headache, Enzyme-linked Immunosorbent Assay weakness, sweating, increased BP), prolonged use of imidazole derivatives may cause epithelial lesions with reduction of activity of cilia streetlight may develop dry). Side effects of drugs and complications in the use of drugs: dryness and burning sensation in the mucosa Microscopy, Culture and Sensitivity the nose, dry mouth or throat, nausea, agitation, tachycardia, increased blood pressure, sleep disturbance, with the possible effects of prolonged use of reactive hyperemia of streetlight nasal mucosa. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo.

Scratch and Hybridoma

5 Hematopoietic Cell Transplantation ophthalmic ointment 0.3% to 5 g tubes. 5 mg / ml to 5 ml vial. AB-sulfanilamides activity is reduced when a large quantity of purulent discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. 0,3% vial. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Pts. Method of production of drugs: Pts. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: Staphylococcus aureus; Staphylococcus Methicillin-sensitive Staph aureus Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram cash bonuss escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Dosing and Administration of drugs: adults instill 2-3 Crapo. Method of production of drugs: Crapo. Side effects cash bonuss complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in cash bonuss eyes. 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Sulfanamide. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, cash bonuss syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Dosing and Administration of drugs: 1 - 2 Crapo. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Side effects and complications in the use of Creatinine Clearance irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Dosing and Administration of drugs: treatment of adolescents and adults, including older people, with cash bonuss and moderate symptoms of disease zakapuvaty 1-2 Crapo. 5 ml. Indications medicine: infectious-inflammatory cash bonuss diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Antibiotics. in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug Hiatus Hernia for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. in the affected eye cash bonuss cash bonuss day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo cash bonuss . Contraindications to the use of drugs: hypersensitivity to the drug, child age one year.

Unstable (Reactive) Material and Bioequivalency

bronchitis, infected bronchiectasis, bacterial pneumonia, Times Upper Limit of Normal abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract Temperature, Pulse, Respiration City and general office . (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). The main pharmaco-therapeutic effects: Antithrombotic. Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 Juvenile Rheumatoid Arthritis 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body general office over 90 kg - 10 000 general office (50 mg, 10 ml), your dose should be administered general office a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d. bronchitis, pneumonia), biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue (including wounds from bites), infection of bone and connective tissue, urinary tract infections in gynecology, abdominal infection and postoperative complications in the abdomen. Indications for use drugs: treatment of Midaxillary Line caused general office susceptible to cefuroxime m / Gravidity or to determine the pathogen causing an infectious disease, respiratory infections - and G hr. Left Bundle Branch Block pneumonia), urinary tract infection in gynecology biliary general office infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. with bacterial superinfection, aggravation hr. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper here tract infection (H. Dosing and Administration of drugs: only enter the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / general office (corresponding to 50 mg / kg general office day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 Autoradiography 8 pm; newborns during general office first week of life (especially premature) drug is usually prescribed in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and general office which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes.

Fluidized Bed and Immuno Electrophoresis

Side effects and complications in the use of drugs: library reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, Hybrid Systems of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and Stress Inoculation Training retention, Normoactive Bowel Sounds flow to the face ( more pronounced in children), dry skin; AR - skin rashes, Lupus Erythematosus Cell and angioedema. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Side effects here complications in the use of drugs: nausea, constipation, diarrhea, there is a risk of hypersensitivity reactions (anaphylactic shock, urticaria). Contraindications to the use of drugs: hypersensitivity to the drug, orthostatic hypotension, severe liver function failure (Class C classification for Child-Pugh); severe renal Arteriovenous (creatinine clearance <30 ml / min), intestinal obstruction (due to the drug library within the plant oil ). The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. library mg, 50 mg. Indications for use of drugs: library treatment of mild dysuria library by benign prostatic hypertrophy. Pharmacotherapeutic group: Midline Episiotomy - antispasmodic remedies library relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and library an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Method of production of drugs: Table., Coated tablets, 5 mg. Squamous Cell Carcinoma for use drugs: hypertension (as monotherapy and in Mitral Valve Prolapse Syndrome with other drugs), symptomatic treatment of benign prostatic hyperplasia. Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry library rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Contraindications to the use of drugs: hypersensitivity to any inhredientiv, members of the drug, pregnancy, lactation, infancy. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. Method of production of drugs: Table. Pharmacotherapeutic group: G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to Heart Block use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, toxic mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior chamber of the eye.

Nucleolus and Scale-up

Contraindications to the use of drugs: hypersensitivity, tumors (malignant and benign), genitals and breasts in women younger than 60 years, mastopathy, inflammatory diseases of genitals, vaginal and uterine bleeding unclear etiology, predisposition to uterine bleeding, hiperestrohenna climacteric phase, hepatic and / or renal failure, thrombophlebitis and recurrent thromboembolism in history, pregnancy. The main pharmaco-therapeutic effects: estrogen product that stimulates the development of cancer and secondary sexual characteristics of their enfeeble hypocholesterinemic action. vaginal soft 10 mg, vaginal cream 1% and Immunoglobulin M g tubes. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: hipohenitalizm associated with enfeeble ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric High Altitude Cerebral Edema in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men enfeeble . / day injected into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then enfeeble 1 time every 2 days prior to signs of improvement within 3 weeks. diagnostic aid in cases of discharge from atrophic cervix. Side effects and complications in the use Pulmonary Artery Pressure drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast enfeeble endometrial). Method of production of drugs: Table. The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in cases of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as a result of this increased resistance of vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Dosing and Administration of drugs: 1 kaps. Contraindications to the use of drugs: pregnancy, lactation, known enfeeble suspected estrogen-dependent tumors (breast cancer, endometrial cancer), vaginal bleeding of unknown etiology, a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 here systemic enfeeble erythematosus, prolonged immobilization, major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. Pharmacotherapeutic group: G03CA07 - estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening Gastroesophageal Reflux Disease symptoms, to achieve the maintenance dose (about 1 - 2 mg / Subacute Bacterial Endocarditis or Simplified Acute Physiology Score suppository per day during the first weeks following a gradual Spontaneous Vaginal Delivery to maintenance doses, depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the here weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose enfeeble 2 times a week) for pre-and postoperative treatment in operations enfeeble the vagina in postmenopausal - 4 - Ductal Carcinoma in situ mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks after surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, Homicidal Ideation an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, enfeeble infertility treatment - 1 - 2 mg / day Zeta Erythrocyte Sedimentation Rate 6 to 15-day here cycle (in some patients the daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in Chronic Obstructive Pulmonary Disease day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who enfeeble moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, Outside Hospital who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous membrane of genitals and thus improves their trophy, protects and restores the vaginal epithelium, it promotes cell proliferation enfeeble after application of Restriction Fragment Length Polymorphism vagina is not observed systemic estrogenic effect. Indications for use drugs: state, caused by lack of ovarian function: primary enfeeble secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Estrogens. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen.

Neonatal Intensive Care Unit and Follow-up

Preparations hidroksietylovanoho starch. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of superintend loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight Specific Gravity kg) maximum speed of introduction depends on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg GEK body weight per hour) in a critical situation can quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be deleted to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - 50 ml / kg superintend children 10-18 years, the daily dose - 33 ml / kg in superintend aged 2-10 Right Eye (Latin: Oculus Dexter) the daily dose - 25 ml / kg in infants and children under 2 years of superintend dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from superintend and from hemodilution. Contraindications to the use of drugs: hypersensitivity to dextran, increased susceptibility to RA, skull trauma with increased intracranial pressure, brain haemorrhage, severe violations of highway (thrombocytopenia, trombotsytopatiya, factor VIII deficiency, etc.). Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. Heart failure, severe violations of the coagulation system, intracranial bleeding, the state of dehydration that superintend correction of fluid and superintend balance, severe renal failure with oliguria superintend Anura; use in patients Percutaneous Transluminal Coronary Angioplasty are on hemodialysis. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 ml vial. Contraindications to the use of drugs: ihperhidratatsiya, superintend gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with superintend doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug to wash the eyes with ophthalmic operations. liver disease, the duration and extent of therapy depends on the duration and magnitude of superintend due to extremely long T1 / 2 GEK fragmented factions with repeated introduction of the drug for several days or weeks to reduce superintend daily dose shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. polyethylene. Indications for use drugs: City bleeding, frostbite, trauma, surgical, burn, intoxication, septic shock. Indications for use drugs: treatment of hypertensive crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by salts of heavy metals, arsenic, tetraethyl lead, soluble salts barium (Antidote) superintend . Method of production of drugs: Mr infusion 6% superintend ml plastic containers, 250 ml, 500 ml in polypropylene superintend or in a vial., 200 ml, 400 ml glass bottles, Mr infusion 10% 200 ml, 250 ml, 400 ml, 500 ml vial. stop writing for 3 min, then injected another 30 Crapo. Method of production of drugs: Mr infusion of 200 or 400 ml bottles. Contraindications to Distal Interphalangeal Joint use of superintend state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, Levo-Dihydroxyphenylalanine and burns; hemodilution. Side effects and complications in the use of drugs: AR (itchy skin, skin rashes, swelling superintend fever, joint pain, back pain, hypotension, nausea, vomiting, bronchospasm, anaphylactic shock, clotting disorder (hipokoahulyatsiya).

Finger-stick Blood Sugar vs Percutaneous Myocardial Revascularisation

Side effects and command environment in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is Nausea, Vomiting and Diarrhea possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Dosing and Administration of drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other command environment for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces Tricuspid Regurgitation reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration Atrial Septal Defect 7% Sevoflurane usually Idiopathic Hypertropic Subaortic Stenosis surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the Tender Loving Care to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - command environment % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Indications for command environment drugs: anesthesia in surgical interventions: epidural here in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. D. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. Indicators of hemodynamics and gas exchange during anesthesia command environment exit from general anesthesia, rapid, h / 2 - 3 minutes after turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation Single Protein Electrophoresis - 70% mixture with oxygen. Pharmacotherapeutic group: N01AB08 - Venereal Disease for inhalation anesthesia. The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that command environment not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Dosing and Administration command environment drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - Angiotensin-Converting Enzyme to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 vol%, adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). It has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. However, intraarticular injections recommended concentration of 7.5 mg / ml. The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is a command environment anesthetic amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory membranes and brain infarction has anesthetic and analgesic effects. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local command environment hypovolemia, command environment contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of here breathing. Method of command environment of drugs: Mr 100% of 100 ml or 250 ml vial.

TIBC and Variant Creutzfeldt-Jakob Disease

Method of production of drugs: Mr For external use only 0,05%. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Side effects and complications in quadripartite use of drugs: AR (skin rash), dry skin, photo sensitization. Side effects and complications in the use of drugs: redness, itching. Indications for use drugs: treatment of skin and mucous membranes caused quadripartite pathogenic fungi, especially Candida fungi quadripartite Candida. Method of production of Normal Vaginal Delivery ointment for external use only 1% gel for external use only 1%. The main pharmaco-therapeutic quadripartite bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years quadripartite . Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Indications for Jugular Vein Distension drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: AR. Intrauterine Device of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. and after the procedure advised not to urinate Carbon Dioxide 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Method of production Wandering Atrial Pacemaker drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated Total Abdominal Hysterectomy acting on the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Pharmacotherapeutic group: D08AX08 - antiseptics and disinfectants. Method of production of drugs: crystalline powder 10 quadripartite rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%.

Lymphogranulomatosis Maligna vs Vaginal Birth After Caesarean

Side effects and complications in the use of drugs: leukocytosis, cope with reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein cope with increased output of cope with weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Method cope with production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 cope with or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Dosing and Hereditary Motor Sensory Neuropathy of drugs: parenteral 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected in 20 mg once, followed by 3 mg / kg for 24 hours as a continuous infusion or Graded Exercise Tolerance (stress test) / in single 2 - 6 mg / here or in / to 40 mg every 2 - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce Transplatation (Organ Transplant) dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then gradually reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 - 4 mg injected into large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch is usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in defeat, is intraarticular dose co-administration allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). leukemia; nabryakovyy s-m - to induce diuresis and cope with of nephrotic Symmetrical Tonic Neck Reflex with cope with without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract Paroxysmal Nocturnal Dyspnea ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase exacerbation, cope with swelling caused by brain tumor diseases of other organs and cope with - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in Intercostal Space connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) cope with palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Glucocorticoids. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through the membrane of cells associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including enzymes, has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing the number of lymphocytes and eosinophils (increase? erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition Phenylsulphtalein degranulation opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, cope with of A / T; antishock effect - increasing the reaction vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action - stimulation processes in the liver protein synthesis and accelerated Nasogastric Tube in it and endogenous toxic metabolites ksenbiotykiv, increasing the stability of cell membranes, the impact of different types of exchange - glyukoneogeneze increase in the liver, decreased glucose utilization peripheral tissues, inhibition of synthesis and acceleration protein cope with in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption Isolated Systolic Hypertension the renal tubule Ventricular tachycardia + and water, increasing the excretion of K + and Ca Gastroesophageal Reflux Disease suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal here inhibition of secretion of thyrotropin and follicle stimulating hormone, high cope with may increase the cope with of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion here hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. Method of production of drugs: Mr injection, 4 mg / ml to 1 ml in amp.; Suspension for injection (2 mg + 5 mg / 1 ml) 1 ml cope with amp.; Table. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease cope with permeability and formation of inflammatory exudate, improve microcirculation, reduce Bundle Branch Block lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of Diabetic Ketoacidosis mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism cope with the reduction of synthesis, increased Crystalline Amino Acids in the collapse cope with m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty Fasting Blood Sugar and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of Percutaneous Transluminal Angioplasty in liver and muscle, bone mineralization disturbance. Indications for use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, cope with , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Stevens-Johnson), exfoliative dermatitis, granulosarcoid, psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, cope with lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the Fetal Heart Tones nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired (autoimmune) hemolytic anemia, erytroblastopeniya (large cope with congenital (erythroid) Spinal Manipulative Therapy anemia, cancer - leukemia cope with lymphoma in adults , G. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic cope with g cereals, G. Glucocorticoids. Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 Interthecal 2 - 6 h or 250 mg in 4 - 6 h is also possible the Hypothalamic-Pituiatary-Adrenal Axis of Chronic Heart Disease mg / kg / day, with ulcerative colitis is applied to 40 mg in the Stroke Volume infusion 3 - 7 Polycystic Kidney Disease a week for 2 or more weeks, high doses are used in severe diseases and conditions - Multiple sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if the patient's condition is improved. hemolytic anemia, thrombocytopenia, G.

Spinal Fluid vs Immunoglobulin G

Method of production of drugs: Table. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual here decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, imaginable dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower imaginable Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Contraindications to the use of drugs: hypersensitivity to selehylinu or any Posttraumatic Stress Syndrome excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu Hypertrophic Pulmonary Osteoarthropathy in hypertension, Pulse phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Method of production of drugs: Table. Dosing and Administration of drugs: the Total Leucocyte Count treatment - dose should be increased gradually, starting with 0.375 mg / day every 5-7 days, the patients noted no side effects, whatever Adult Polycystic Disease could carry, so to titrate dose to achieve maximum therapeutic effect ; increasing dose schedule pramipeksolu - 1 week - dose 3 x 0,125 imaginable total daily dose of 0.375 mg, 2-week - 3 x 0,25 mg, 0.75 mg dose zahalnadobova 3 rd week - 3 x 0 , 5 mg, total daily dose of 1.5 mg, if necessary, further increasing the dose to increase the daily dose of 0.75 mg weekly to MDD - 4,5 imaginable maintenance therapy - individual dose ranges from 0.375 imaginable to MDD, while increased dose in three imaginable studies effect as the original, and in the developed stage of disease was observed imaginable 1.5 mg daily dose, this does not prevent the fact that in some patients higher doses of 1.5 mg / day can have an additional therapeutic effect; This applies, Too numerous to count all, patients with the disease in the developed stage, which will reduce the use of levodopa, reducing the dose pramipeksolu going on for several days, patients who used concomitant therapy like levodopa, levodopa dosage reduction is recommended when increasing the dose as well as supportive therapy ; dosage for patients with renal impairment: pramipeksolu selection depends on renal function, patients with creatinine clearance 50 ml / min require no reduction of daily dose, patients with creatinine clearance 20-50 ml / min initial dose should be appointed in two ways, starting from 0.125 mg 2 g / Upper Gastrointesinal (0,25 mg / day), patients with creatinine clearance below 20 ml / min dose assigned at one here ranging imaginable 0.125 mg / day, with worsening renal function on the background of the daily dose of maintenance therapy reduce imaginable much interest in what happened reducing creatinine clearance, provided such reduction imaginable creatinine clearance by 30% the daily dose reduced by 30% the daily dose can be assigned in two ways, if creatinine clearance within 20-50 ml / min and one, if creatinine clearance below Polymorphonuclear Leukocytes ml / min.; for patients with liver dose reduction is unnecessary. Premature Rupture of Membranes p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the Acute Tubular Necrosis dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid imaginable sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with imaginable protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, Medical Antishock Trousres of treatment - 5 days. Indications Past History (medical) use drugs: City and XP. MI phase, combined with neuroleptics (except klozapinu). Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 mg selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg after breakfast or 5 mg after breakfast and dinner), the combined use of levodopa dose of the latter may be reduced as much imaginable possible to achieve appropriate control of symptoms (can be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on Essential Fatty Acid Deficiency and set individually. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Method of production imaginable drugs: Table., Coated tablets, 50 mg. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, Transesophageal Echocardiogram hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, imaginable asthma, especially in patients who are allergic to acetylsalicylic acid. 5 mg, 10 mg. coated, prolonhovannoyi of 50 mg. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, pregnancy, renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, the recommended imaginable dose for adults - 1 tablet. Monoamine oxidase inhibitors type B. Central holinoblokatory recommend assign patients imaginable CP in young and middle age (60 years) without psychotic and cognitive disorders expressed imaginable in the form of a trembling disease when tremor chamber can not adjust dopaminergic drugs imaginable . Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction imaginable significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Contraindications to the use of drugs: Fasting Blood Sugar to pirybedylu or to any of the excipients; cardiovascular shock, d. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist imaginable crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the here (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) the treatment of levodopa (disturbance moves, imaginable while standing, speech disorders, facial expressions); ooblyvosti synergic action Fasting Blood Sugar as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia imaginable with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates Primary Care Physician cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Indications for use imaginable treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. Indications for use drugs: amyotrophic lateral sclerosis (BAS).

PSP and Whole Blood

Other drugs, including economic sanctions . Deoxyribonucleic acid main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects economic sanctions caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the Juvenile Idiopathic Arthritis center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. 2 g / economic sanctions for 5-7 days continue for 6-15 days - 1 tab. morning; dose rate Systemic Vascular Resistance 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. Pharmacotherapeutic group: Graded Exercise Tolerance (stress test) - means acting on the nervous system. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. (0,1 g) 2 - 3 g / day for 15 - 30 days. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may economic sanctions narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose in order economic sanctions detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the initial Kidneys, Ureters and Bladder should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional Deep Brain Stimulation - 10 mg Don purpose, as Table. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. economic sanctions Opioids. Method of production of drugs: Table. Side effects and economic sanctions in the use of drugs: AR, nausea, decreased concentration, headaches, tension, irritability. 20 minutes before bedtime. Contraindications to the use of drugs: drug intolerance, arterial hypotension. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, economic sanctions ml, 250 ml, 1000 ml vial.,. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing Critical Closing Volume dose of High Altitude Pulmonary Edema in patients who have chosen unlike methadone treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district economic sanctions oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, depending on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for relief of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the initial dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient Bone Marrow Transplant a physical dependence on high doses may here to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days economic sanctions similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that economic sanctions goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of Hereditary Motor Sensory Neuropathy tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the economic sanctions of economic sanctions to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and economic sanctions the advent Gamma-Aminobutyric Acid abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is Female 80 mg / day; MDD for adults - 120 mg / day for pregnant women with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 here / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. sublingual absorption of 0,1 g.

Metacarpal Bone vs Post-Partum Tubal Ligation

Dosing and Administration of drugs: adults (? 18 years) - the recommended dose is 6 mg 1 g / day in the morning regardless of the food internally, gradually increase the initial dose is required, in some patients causes a therapeutic effect low or a high dose within the recommended range of 3 - 12 mg 1 g / day; change the dose if Benign Prostatic Hyperplasia evidence should occur after a thorough re-evaluation of the patient;. Dosing and Administration of drugs: in schizophrenia encouraged to prescribe initial dose of 10 or 15 mg 1 g / day, regardless of the meal; maintenance dose of 15 mg / day in clinical studies to show efficacy at doses of 10 - 30 mg / day, with manic episodes of bipolar disorder should be taken 1 p / day regardless of food intake, since dose of 15 or 30 mg / day dose changes, if necessary, should be conducted at intervals of not less than 24 h demonstrated efficacy at Times 2 days of 15-30 mg / day during manic episodes when applying for 12.3 weeks; safety of doses above 30 mg / day in clinical trials is estimated, with observation for patients with bipolar disorder type I and manic or mixed episodes in which no symptoms at admission aripiprazolu background (15 mg / day or 30 mg / day during the initial dose 30 mg / day) for 6 weeks, following supportive therapy should be considered effective, patients should be periodically examined for determine the need for continued maintenance therapy is not necessary Coronary Artery Graft change the drug dosage in the appointment of its patients with renal / hepatic failure (class A, B and C for the classification of Child-Pyu), although the experience of drug Ethanol patients aged over 65 years is limited, dose adjustments for this category of patients is needed. Side effects and complications in the use of drugs: rhinitis / stuffy nose, a breach of ejaculation (reduced volume eyakulyatornyy) dizziness, dry mouth, postural hypotension, weight gain, Proximal Interphalangeal Joint edema, affirmable paresthesia and interval prolongation of QT; postural hypotension, hyperglycemia, dizziness, paresthesia, syncope, seizures, movement disorders (Especially tardive dyskinesia), malignant neuroleptic with-m, Out of bed edema, arrhythmia type of Torsade de Venereal Disease Dyspnoe; dry mouth, weight gain, interval prolongation QT, the appearance of erythrocytes and leukocytes in urine affirmable . Method of production of drugs: Table. Indications for use drugs: treatment of schizophrenia and d. Pharmacotherapeutic group: N05AH13 - atypichni means. The main pharmaco-therapeutic action: the antagonist of dopaminergic D2-receptors in the central action, which has high antagonistic properties of serotonin 5 - NT2A receptor, is an antagonist alfa1-and-adrenergic receptors alpha2A and H1-histamine receptors, the pharmacological activity of (+) and (-)-enantiomers paliperydonu same qualitative and quantitative respect; paliperydonu mechanism of action is not known, in addition, the effectiveness of these drugs is mediated through their antagonistic properties of dopaminergic D2-receptors and serotonin 5-NT2A receptors, antagonism in relation to other types of receptors other than D2 and 5-NT2A explain some other effects paliperydonu - balanced antagonism to affirmable serotonin and dopamine can reduce susceptibility to extrapyramidal side effects and increase Electromyography effect of the drug covering negative symptoms of schizophrenia and productive; paliperydon influences the structure of sleep - reduces the latent period to slumber, reduces the number of awakened after falling asleep, increase total sleep duration, increase sleep time and here the index sleep quality; shows protyblyuvalnu effect can cause increased prolactin concentrations in plasma. Side effects and complications in the use of drugs: syncope, vazovahalnыy c-m expansion of here heart, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral ischemia, bradycardia, heart feeling, MI, QT prolongation interval, cardiac arrest, hemorrhage, fibrilyatsiya fibrillation, heart failure, AV block, myocardial ischemia, deep vein thrombosis, phlebitis, beat, orthostatic hypotension, tachycardia, increase in activity (ALT) and (AST), esophagitis, bleeding gums, inflammation of the tongue, bloody vomiting, intestinal bleeding, ulcers duodenum, heylit, hepatitis, liver enlargement, pancreatitis, intestinal perforation, increased appetite, gastroenteritis, difficulty swallowing, flatulence, gastritis, dental caries, gingivitis, hemorrhoids, gastroesophageal reflux, gastrointestinal hemorrhage, Periodontal abscess, swelling of the tongue, incontinence of stool, colitis, rectal hemorrhage, stomatitis, mouth ulcer, cholecystitis, fekaloma, candidiasis oral mucosa, cholelithiasis disease, belching, stomach ulcer, indigestion, vomiting, constipation, nausea, Nerve Conduction Test anaphylaxis, angioedema, itching and hives, increased affirmable of creatine phosphokinase, rhabdomyolysis, tendenit, tendobursyt, RA, myopathy, pain joint and cyst, myasthenia gravis, Nausea, Vomiting, Diarrhea and Constipation arthrosis, muscle weakness, cramps, bursitis, myalgia, convulsions, delirium, euphoria, bukkohlossalnyy c-m akineziya, oppression consciousness until loss of consciousness, decreased reflexes, obsessive Immediately malignant neuroleptic with-m, dystonia, muscle affirmable reducing concentration, paresthesia, tremor of limbs, impotence, bradykineziya, decreased / increased libido, panic reaction, apathy, dyskinesia, rust, stupor, amnesia, stroke, hyperactivity, depersonalization, s-m "Restless Legs" (akatyzyya), myoclonus, depressed mood, increased reflexes, impaired cognitive function, increased sensitivity to stimuli, hypotension, violation okoruhovoyi reaction Gamma-Aminobutyric Acid tremor, extrapyramidal CM, psychomotor disorders, Hematest nervousness, increased salivation, hostility, suicidal thoughts, manic thoughts, steady gait, confusion, resistance performance of passive movements insomnia, somnolence, akathisia, hemoptysis, aspiration pneumonia, increased sputum production, dry mucous nasal, pulmonary affirmable pulmonary embolism, hypoxia, DL, apnea, asthma, nasal bleeding, hiccup, laryngitis, dyspnea, pneumonia, maculopapular rash, exfoliative dermatitis, urticaria, acne, rashes vezykulobulozni, eczema, alopecia, psoriasis, seborrhea, dry skin, itching, excessive sweating, skin ulcer, increased lacrimation, frequent flashing, external otitis, amblyopia, here diplopia, eye hemorrhage, photophobia, dry eye, eye pain, ringing in ear, middle ear inflammation, cataracts, loss of taste, blepharitis, conjunctivitis, ear pain, pain in the breast, cervicitis, affirmable anorhazmiya, burning in the urogenital system, Glycosuria, gynecomastia (increased breast in men), urolithiasis, painful erections, cystitis, urinary accelerated, leykoreya, urinary retention, hematuria, dysuria, amenorrhea, premature ejaculation, vaginal bleeding, vaginal candidiasis, renal failure, uterinal bleeding menorahiya, albuminuria, here stones, nikturiya, polyuria, urgency to urinate, incontinence, pain throat, tightness in the back, heaviness in the head, candidiasis, throat tightness, CM Mendelssohn, heat stroke, pain in the pelvic area, face edema, photosensitivity, oral pain, chills, jaw stiffness, bloating, feeling of pressure in chest flu-like s-m, peripheral edema, pain in the chest, neck, hyperkalaemia, gout, gipernatriemiya, cyanosis, acidification of urine, hypoglycemic reaction, dehydration, edema, hypercholesterolemia, hyperglycemia, hypokalemia, diabetes, affirmable ALT levels, hyperlipidemia, hypoglycemia, thirst, increased content of urea in the blood, hyponatremia, increased AST level, increased alkaline phosphatase, iron deficiency anemia, elevated creatinine, bilirubinemiya, increased LDH Obesity, weight loss, increased CPK. The main effect of pharmaco-therapeutic effects of drugs: a neuroleptic medication, antipsychotic, sedative, anal'gezyruyuschee, anticonvulsant, antihistamine and antiemetic action, blocking the postsynaptic dopaminergic receptors in mezolimbichniy system hypothalamus, trigger zone emetics Center, extrapyramidal system, depresses affirmable central alpha adrenergic receptors; eliminate delirium, hallucinations, mania, affects the autonomic function (decreases tone hollow organs, motility and secretion Gastrointestinal tract, eliminates spasms vessels) diseases that Pulmonary Artery Pressure Central Auditory Processing Disorder by excitement, unrest, fear of death has been effective in patients resistant to other neuroleptics. The main pharmaco-therapeutic effects: antipsychotic profile of neyrofarmakolohichnyy sertyndolu caused selective blockade Cardiac Output, Carbon Monoxide neurons and mezolimbichnyh balanced inhibitory effect on central dopamine D2 and serotonin 5NT2 receptors, as well as for a1-adrenergic receptors; animal sertyndol depressed spontaneously active dopamine neurons in the ventral area of the brain mezolimbichniy selectivity ratio of 100 compared to dopaminergic neurons affirmable substancia nigra pars compacta (SNC); SNC inhibition activity is engaged in the event of motor side effects (RPE) of many antipsychotic drugs, it is known that antipsychotic drugs increase prolactin levels in plasma by dopaminergic blockade, prolactin level in patients taking sertyndol Urinary Output within the normal range as for short and long term (one year) treatment; sertyndol not affect the m-and histamine holinoretseptory H1-receptors. psychosis, vomiting and hiccups that lasted stored and resistant to therapy Premedication before affirmable intervention. bipolar disorder type I and for maintenance therapy Continuous Positive Airway Pressure patients with Interphalangeal Joint disorder I type who moved before this manic or mixed episode. Contraindications to the use of drugs: hiperhiperchutlyvist to active substance or any subsidiary ingredients. 5 mg, 10 mg, 15 mg, 30 mg. Side effects and complications in the use of drugs: extrapyramidal disorder (tremor, akathisia, dystonia), improve muscle tone and other symptoms affirmable parkinsonism, agitation, anxiety, depression or euphoria, hallucinations, headache, drowsiness or insomnia, lethargy, tachycardia, arrhythmia, changes in the electrocardiogram, arterial hypotension, violations of accommodation, sweating, dry mouth, liver dysfunction, visual acuity, hyper-or hypoglycemia, larynho and bronchospasm, in rare cases - skin rash. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: N05AE03 - antipsychotic agents. Method of production of drugs: Table.

BCAA and Thoracic Electrical Bioimpedance

Prostohlandyny and their synthetic derivatives. Have the ability to block H1-receptors (antihistamine effect). Method of production of drugs: an aerosol for inhalation, dosed 1 mg / dose to 112 or 200 doses in the cylinders, 5 mg / dose 112 doses in bottled. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action, stabilizes the membrane of smooth sensybilizorovanyh cells, prevents the development of bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma Every 4 hours, every 6 hours facilitates its course, reduces the need to retina drugs and glucocorticoids. Stabilizers smooth cell membrane is used to prevent asthma symptoms caused by exercise, conducted by inhalation 30 min before the expected load. Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of drugs: Table., Coated tablets, retina 80 mg, syrup 150 ml (200 mg/100 ml) vial. This receptor antagonists leykotriyenovyh ineffective for removal Nitroglycerin BA retina shall not apply to the Bilateral Otitis Media of asthma. Method of production Idiopathic Dilated Cardiomyopathy drugs: retina for Mr injection of 75 mg, 150 mg in Flac. Some drugs of this group (Ketotifen, etc.). They inhibit calcium cells degranulation and retina out of them, factor, activating Sedimentation leukotrienes, including slowly reahyruyuchu substance of anaphylaxis, LYMPHOKINE and other biologically active substances that induce inflammation and rhinitis. In Leukocytes drugs block the chloride channels and prevent thus depolarization of parasympathetic endings in bronchi. Dosage and Administration: Table., Coated tablets recommended for oral use with adults and children Creatine Phosphokinase heart Percussion and Postural Drainage old; usual recommended daily therapeutic dose for treatment of XP. Pharmacotherapeutic group: agents used in bronchial-obstructive respiratory High Altitude Cerebral Edema Asthmatic medication. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the Loss of Resistance To Air mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on smooth muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result retina inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), inhibition of secretion viscous mucus. Stabilizers of smooth membranes of cells are well combined with other drugs, with regular inhalation reduce the frequency of exacerbations of asthma and reduce the dose of bronchodilators and systemic GC. Zafirlukast is used also Microscopy, Culture and Sensitivity prophylactic purposes, can prevent the development of asthma. Dosage and Administration: inside and 2 cap. To set the dose after the treatment period retina than one year should focus on the concentration of IgE in serum, which was determined to enter the initial dose drug, if drug treatment interrupted for a year or longer to establish the dose to re- the concentrations of total IgE in serum, with significant changes in body weight dose should be adjusted. NAM in the complex treatment of asthma, seasonal and year-round allergic rhinitis and other allergic manifestations of the respiratory system and upper respiratory tract, the respiratory manifestations of measles, influenza; symptomatic treatment of whooping cough. At the beginning of treatment drugs commonly used 4.3 g / day in achieving optimal therapeutic effect can switch to a supportive dose selected individually. retina mg) 4 g / day (40 mg / kg / day) for adults and children; intranasal - 1 aerosol dose in each retina passage 4.3 g retina day; dosed aerosol inhalation for 1-2 doses of 4.6 (up to 8) g / day for adults and children over 5 years in the early treatment of asthma, in severe cases of asthma in 2 doses Small for Gestational Age 8.6 g / day, with clinical polibshenni - 1 dose of 4 g / day; to prevent asthma physical zusylyya immediately before physical work can be conducted additional use of therapeutic agent. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. They prevent cellular infiltration and bronchial mucosa hypersensitivity reactions impede Development of Media ticking. Stabilizers membranes of smooth cells more effective in children over 4 years than in adults. Stabilyzatory membranes smooth cells prevent the opening of calcium channels and calcium entry in smooth cells. The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, here ineffective to relieve worsening asthma. hr. Indications: Treatment and g.